How These Therapies Are Used in Clinical Care

MR4 laser therapy and Celluma light therapy deliver controlled light energy to targeted areas as part of a broader treatment strategy. They are used to support pain-focused care and functional improvement within a comprehensive medical plan.

These modalities are not stand-alone solutions. Instead, they are integrated with clinical evaluation, physical examination, imaging review when appropriate, and other treatment strategies tailored to the patient’s condition.

In injury-related cases — including motor vehicle accidents and other trauma — these therapies may be incorporated when consistent with the patient’s diagnosis, symptoms, and functional limitations. Their use is based on medical necessity and response to care.

From a documentation perspective, treatment is recorded in a manner that aligns objective findings with clinical decision-making. This supports clarity for patients, providers, attorneys, and insurers reviewing the medical record.

FDA Clearance and Why It Matters

We emphasize FDA clearance because it is important that patients and reviewers understand these are regulated medical devices with defined intended uses.

MR4 Laser

The MR4 Laser is FDA-cleared under 510(k) K171354 as a powered light-based laser device for adjunctive use in pain therapy. Manufacturer documentation states this includes temporary relief of minor chronic neck and shoulder pain of musculoskeletal origin.

Celluma

Celluma devices have FDA-cleared pain-related indications involving topical heating and the temporary relief of minor muscle and joint pain, arthritis, muscle spasm, stiffness, relaxation of muscle tissue, and temporary increases in local blood circulation.

FDA clearance indicates that a device has been reviewed and cleared for specific intended uses. It does not guarantee outcomes, and it does not replace clinical judgment. At SIPR, these therapies are used within their appropriate medical context as part of patient-specific care plans.

When These Therapies May Be Recommended

Your provider may recommend MR4 laser therapy, Celluma therapy, or a combination approach when clinically appropriate. Common indications include:

• Neck and shoulder pain
• Back pain and soft-tissue irritation
• Muscle spasm or stiffness
• Joint discomfort
• Post-traumatic musculoskeletal pain
• Supportive care during rehabilitation
• Conservative treatment prior to or alongside other interventions

In personal injury cases, treatment decisions are based on medical necessity, clinical findings, and response to care. The goal is appropriate treatment supported by clear, objective documentation.

MR4 Laser Therapy

The MR4 Laser is a light-based therapy device used as an adjunctive modality in pain-focused treatment plans. It is non-invasive and does not involve injections or surgical procedures.

Within clinical care, MR4 laser therapy is applied to targeted areas based on examination findings and patient-reported symptoms. Its role is to support the overall treatment strategy, not to replace other components of care.

Use of this device at SIPR is aligned with its FDA-cleared intended use and is incorporated only when clinically appropriate.

Celluma Therapy

Celluma is a flexible light therapy system used to deliver FDA-cleared pain-related treatments involving topical heating and temporary relief of muscle and joint symptoms.

It may be applied to different areas of the body depending on the patient’s condition and treatment plan. As with MR4 laser therapy, it is used as part of a broader clinical approach focused on symptom management and functional improvement.

In a medical setting, Celluma therapy is documented and used as a therapeutic modality — not as a general wellness or cosmetic service when applied for pain-related treatment.

What to Expect During Your Visit

Before Treatment

• Your provider will review your symptoms, diagnosis, and treatment goals
• The treatment area will be identified based on clinical findings
• A determination will be made whether these therapies are appropriate

During Treatment

• Treatment is non-invasive and typically well tolerated
• The device is positioned over the targeted area
• The session is performed according to the clinical treatment plan
• No injections or surgical procedures are involved

After Treatment

• Most patients can resume normal activity unless otherwise directed
• Response to treatment is monitored over time
• Additional sessions may be recommended based on progress

Important Clinical Note

These therapies are one component of a comprehensive medical treatment plan. No single modality determines diagnosis, prognosis, or outcome.

Response to treatment varies based on:

• Type and severity of injury
• Duration of symptoms
• Individual health factors
• Concurrent treatments

FDA clearance confirms appropriate device classification and intended use. It does not guarantee specific results and should be interpreted within the context of clinical care.

Our Approach at SIPR

Our focus is to provide clinically appropriate, well-documented, and clearly communicated care.

• Use of FDA-cleared therapies within their proper medical role
• Objective, defensible documentation
• Integration with comprehensive treatment planning
• Clear communication for patients, providers, attorneys, and insurers

Frequently Asked Questions

Are these therapies FDA-cleared?

Yes. MR4 Laser and Celluma devices are FDA-cleared for specific intended uses related to pain therapy.

Do they guarantee results?

No. FDA clearance does not guarantee outcomes. Response varies by patient and clinical condition.

Are these treatments invasive?

No. These are non-invasive therapies with no injections or surgical procedures.

Can these be used in personal injury cases?

Yes, when medically indicated. Treatment must align with clinical findings and be properly documented.

Can records be requested?

Yes, in accordance with applicable privacy laws and authorization.

Request an Appointment

If you are experiencing pain following an injury, contact SIPR to determine whether these therapies may be appropriate for your treatment plan.

Contact SIPR

Back to Services